| Control group | Group-1 | Group-2 | Group-3 | nab-P | AP | |
---|---|---|---|---|---|---|---|
WB (relative gray value) | Bax | 0.03 ± 0.00 | 0.15 ± 0.01** | 0.14 ± 0.01** | 0.14 ± 0.01** | 0.10 ± 0.02** | 0.09 ± 0.00** |
bcl-2 | 0.24 ± 0.01 | 0.06 ± 0.01** | 0.06 ± 0.01** | 0.06 ± 0.01** | 0.18 ± 0.01** | 0.19 ± 0.02** | |
p-VEGFR-2 | 0.14 ± 0.01 | 0.03 ± 0.00** | 0.04 ± 0.00** | 0.04 ± 0.00** | 0.13 ± 0.01 | 0.09 ± 0.00** | |
MMP-2 | 0.16 ± 0.01 | 0.03 ± 0.00** | 0.04 ± 0.00** | 0.04 ± 0.00** | 0.09 ± 0.01** | 0.09 ± 0.00** | |
IF (positive rate%) | Bax | 2.7% ± 0.29 | 23.07% ± 1.13** | 21.57% ± 0.67** | 21.8% ± 1.8** | 12.4% ± 1.07** | 10.57% ± 0.68** |
bcl-2 | 25.7% ± 0.65 | 7.57% ± 1.11** | 7.4% ± 1.1** | 8.2% ± 1.2** | 13.33% ± 1.96** | 13.73% ± 0.71** | |
p-VEGFR-2 | 27.8% ± 0.86 | 6.8% ± 1.51** | 7.5% ± 0.94** | 8.4% ± 0.88** | 24.47% ± 2.27 | 17.7% ± 0.52** | |
MMP-2 | 27.1% ± 1.7 | 7.97% ± 1.2** | 9.83% ± 1.01** | 11.13% ± 0.4** | 21.07% ± 1.14** | 22.27% ± 0.97** | |
Transwell (invasion cellular amount) | 391 ± 21.7 | 6 ± 1.3** | 12 ± 2.6** | 14 ± 1.9** | 197 ± 29.9** | 216 ± 26.1** | |
Wound healing (Area recovery%) | 12 h | 63.54 ± 4.48 | −6.56 ± 0.39** | −5.28 ± 0.53** | −4.5 ± 0.39** | 1.03 ± 0.05** | −2.46 ± 0.27** |
24 h | 84.88 ± 2.15 | −14.8 ± 0.7** | −14.37 ± 0.73** | −14.15 ± 0.61** | 1.51 ± 0.07** | −2.51 ± 1.18** |